XML 30 R9.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Activities    
Net loss $ (77,398) $ (21,545)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 69,751 64,498
Amortization of deferred financing costs 2,802 1,687
Equity in net loss (income) from unconsolidated joint ventures 20,780 (1,170)
Distributions of cumulative earnings from unconsolidated joint ventures 159 122
Equity in net loss on sale of interest in unconsolidated joint venture/real estate 814 0
Purchase price and other fair value adjustments (4,183) 9,611
Depreciable real estate reserves and impairments 35,160 8,546
(Gain) loss on sale of real estate, net (16,636) 482
Loan loss reserves and other investment reserves, net of recoveries 0 (25,039)
Deferred rents receivable (2,606) 3,586
Non-cash lease expense 5,549 5,191
Other non-cash adjustments 13,588 9,499
Changes in operating assets and liabilities:    
Tenant and other receivables (12,031) (6,046)
Related party receivables (9,020) 8,334
Deferred lease costs (9,629) (4,469)
Other assets (37,022) (28,978)
Accounts payable, accrued expenses, other liabilities and security deposits 476 (8,182)
Deferred revenue 6,404 (5,097)
Lease liability - operating leases (4,546) (4,320)
Net cash (used in) provided by operating activities (17,588) 6,710
Investing Activities    
Acquisitions of real estate property (664,131) (112,440)
Additions to land, buildings and improvements (103,614) (74,239)
Investments in unconsolidated joint ventures (45,924) (36,786)
Distributions in excess of cumulative earnings from unconsolidated joint ventures 177,610 9,460
Net proceeds from disposition of real estate/joint venture interest 53,714 93,520
Proceeds from sale or redemption of marketable securities 0 10,973
Investments in real estate loans held by consolidated securitization vehicles 0 (49,296)
Other investments 614 (5,679)
Origination or purchase of debt fund investments (139,161) (11,786)
Repayments or redemption of debt and preferred equity investments 28,500 0
Net cash used in investing activities (692,392) (176,273)
Financing Activities    
Proceeds from mortgages and other loans payable 620,418 89,253
Repayments of mortgages and other loans payable (87,401) (3,550)
Proceeds from revolving credit facility, term loans and unsecured notes 670,410 420,000
Repayments of revolving credit facility, term loans and unsecured notes (485,410) (250,000)
Proceeds from stock options exercised and DRSPP issuance 62 75
Proceeds from issuance of common stock 0 (871)
Redemption of OP units (4,595) (11,267)
Distributions to noncontrolling interests in other partnerships (8,320) (221)
Contributions from noncontrolling interests in other partnerships 40,399 3,386
Distributions to noncontrolling interests in the Operating Partnership (3,614) (4,155)
Contributions from noncontrolling interests to debt fund investments 81,725 0
Distributions from debt fund investments (1,821) 0
Dividends paid on common and preferred stock (2,811) (60,196)
Other obligations related to secured borrowing (75,294) 0
Tax withholdings related to restricted share awards (6,283) (6,850)
Deferred loan costs (25,341) (651)
Net cash provided by financing activities 712,124 174,953
Net increase in cash, cash equivalents, and restricted cash 2,144 5,390
Cash, cash equivalents, and restricted cash at beginning of year 336,495 331,638
Cash, cash equivalents, and restricted cash at end of period 338,639 337,028
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Issuance of preferred units relating to a real estate acquisition 5,800 0
Assumption of mortgage loans 12,200 0
Measurement adjustment for redeemable noncontrolling interest 22,901 12,940
Contribution to consolidated joint venture interest 0 51
Transfer of assets related to assets held for sale 211,222 0
Transfer of liabilities related to assets held for sale 189,842 0
Removal of fully depreciated commercial real estate properties 0 1,095
Consolidation of securitization vehicle assets 0 828,143
Consolidation of securitization vehicle liabilities 0 828,143
Cash and cash equivalents 143,867 180,133
Restricted cash 194,772 156,895
Total cash, cash equivalents, and restricted cash $ 338,639 $ 337,028